肝脏与胰腺CT和MR影像的影像组学:具有临床应用潜力的工具
本文为非系统性综述,介绍从肝脏和胰腺CT与MRI实施影像组学及特征提取流程的关键步骤,概述已报道的肝脏与胰腺影像组学应用及其在临床落地中的挑战与局限,并简要探讨未来前景。
要点
- 肝脏影像组学在动脉期改善富血供病变如腺瘤、局灶性结节增生与肝细胞癌的鉴别,并可用于治疗前判断肝细胞癌预后因素(如肿瘤分级、微血管侵犯、Ki-67增殖指数)。
- 胰腺CT与MR影像组学增强了胰腺导管腺癌的检出及其与胰腺神经内分泌肿瘤、肿块型慢性胰腺炎或自身免疫性胰腺炎的鉴别。
- 影像组学可帮助更好表征偶发胰腺囊性病变,准确区分胰腺导管内黏液性肿瘤的良性与恶性。
核心结论
- 影像组学在肝脏与胰腺病变的鉴别、检出和预后判断方面显示出令人鼓舞的结果和令人兴奋的潜力,但这些工具尚未在临床环境中实施。
研究设计与样本
- 非系统性综述,描述从肝脏和胰腺CT与MRI研究实施影像组学及特征提取工作流程的关键步骤。
- 综述范围包括已报道的肝脏与胰腺影像组学应用及其在临床实施中的挑战与局限,并简要探讨未来前景。
- 原文提及临床引入影像组学需要建立标准化的影像组学流程和质量保证项目。
关键影像表现/征象
- 肝脏影像组学与纹理分析在动脉期改善了富血供病变如腺瘤、局灶性结节增生与肝细胞癌的鉴别。
- 肝脏影像组学可用于治疗前判断肝细胞癌预后因素,如肿瘤分级、微血管侵犯、Ki-67增殖指数。
- 胰腺CT与MR影像组学增强了胰腺导管腺癌的检出及其与胰腺神经内分泌肿瘤、肿块型慢性胰腺炎或自身免疫性胰腺炎的鉴别。
- 影像组学可帮助更好表征偶发胰腺囊性病变,准确区分胰腺导管内黏液性肿瘤的良性与恶性。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 尽管结果令人鼓舞且潜力巨大,这些工具尚未在临床环境中实施。
- 临床引入影像组学需要建立标准化的影像组学流程和质量保证项目。
- 原文讨论了影像组学在临床实施中的挑战与局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiomics allows the extraction of quantitative imaging features from clinical magnetic resonance imaging (MRI) and computerized tomography (CT) studies. The advantages of radiomics have primarily been exploited in oncological applications, including better characterization and staging of oncological lesions and prediction of patient outcomes and treatment response. The potential introduction of radiomics in the clinical setting requires the establishment of a standardized radiomics pipeline and a quality assurance program. Radiomics and texture analysis of the liver have improved the differentiation of hypervascular lesions such as adenomas, focal nodular hyperplasia, and hepatocellular carcinoma (HCC) during the arterial phase, and in the pretreatment determination of HCC prognostic factors (e.g., tumor grade, microvascular invasion, Ki-67 proliferation index). Radiomics of pancreatic CT and MR images has enhanced pancreatic ductal adenocarcinoma detection and its differentiation from pancreatic neuroendocrine tumors, mass-forming chronic pancreatitis, or autoimmune pancreatitis. Radiomics can further help to better characterize incidental pancreatic cystic lesions, accurately discriminating benign from malignant intrapancreatic mucinous neoplasms. Nonetheless, despite their encouraging results and exciting potential, these tools have yet to be implemented in the clinical setting. This non-systematic review will describe the essential steps in the implementation of the radiomics and feature extraction workflow from liver and pancreas CT and MRI studies for their potential clinical application. A succinct overview of reported radiomics applications in the liver and pancreas and the challenges and limitations of their implementation in the clinical setting is also discussed, concluding with a brief exploration of the future perspectives of radiomics in the gastroenterology field.
引用
- Berbís MÁ, Godino FP, Rodríguez-Comas J, et al. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application. Abdom Radiol (NY). 2023. PMID: 37889265. doi:10.1007/s00261-023-04071-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。